Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 5.6% – Should You Sell?
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s share price fell 5.6% during trading on...
Your Source for Insightful Trends and Discussions.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s share price fell 5.6% during trading on...
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) COO Peter Radovich sold 3,177 shares of...
Quantum Biopharma (NASDAQ:QNTM – Get Free Report) and ASLAN Pharmaceuticals (NASDAQ:ASLN – Get Free Report)...
Petros Pharmaceuticals (NASDAQ:PTPI – Get Free Report) and MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)...
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) COO Azmi Nabulsi sold 7,886 shares of...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) traded up 3.2% on Wednesday . The...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) CFO Kenneth Allen Myszkowski sold 27,167 shares...
argenx (NASDAQ:ARGX – Get Free Report) and Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) are...